Control of platelet actomyosin activity: effect of ADP on superprecipitation and ATPase activity of human platelet actomyosin.
D000205:Actomyosin / Q000097:blood*; D000244:Adenosine Diphosphate / Q000494:pharmacology*; D000251:Adenosine Triphosphatases / Q000097:blood*; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D002118:Calcium / Q000494:pharmacology; D002614:Chelating Agents / Q000494:pharmacology; D011232:Chemical Precipitation; D004586:Electrophoresis; D006150:Guanine Nucleotides / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D009132:Muscles; D009994:Osmolar Concentration; D010973:Platelet Adhesiveness / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D011189:Potassium Chloride / Q000494:pharmacology; D011817:Rabbits; D013053:Spectrophotometry; D014500:Uracil Nucleotides / Q000494:pharmacology
D002614:Chelating Agents; D006150:Guanine Nucleotides; D014500:Uracil Nucleotides; D000244:Adenosine Diphosphate; D011189:Potassium Chloride; D000255:Adenosine Triphosphate; D000205:Actomyosin; D000251:Adenosine Triphosphatases; D008274:Magnesium; D002118:Calcium